Wistron has reached a joint venture agreement with B-Temia Inc., a Canadian biotechnology company and a leader in exoskeleton robotics. B-Temia Asia will be established in Singapore to bring innovative and intelligent powered lower limb exoskeleton robots, Keeogo™, with the advantages of bilateral cooperation, it's going to be marketed to many countries including China, Japan, and Hong Kong, further expands the Keeogo™ Asian market.

Donald Hwang, Chief Technology Officer of Wistron, said, "Wistron actively develops the application of medical technology to help more people with limited freedom to move their body to restore their mobility. We are very pleased to work with B-Temia to expand the Asian market for intelligent powered lower limb exoskeleton robots. We look forward to combining technology with medical treatment to make human life better. "

B-Temia CEO Stéphane Bédard said, "We are very pleased to further expand and strengthen our relationship with Wistron. Through the cooperation of both parties in the past year, we have effectively transferred our product manufacturing to Asia. Wistron in June 2017, becoming a major shareholder of B-Temia and the joint venture of B-Temia Asia was a very exciting moment for all shareholders of B-Temia and the R&D team. "

From June 7th to June 9th, B-Temia was honored to be invited to showcase the "Keeogo™ Exoskeleton Robot" at the G7 Summit technology platform held in Quebec, Canada. "It is the only company in the robotics field among the twelve participating manufacturers. The media and the public can understand the value of innovative mobile technology through real interaction.

Wistron adheres to the spirit of serving the public to develop medical devices and technology, and cooperates with B-Temia to develop intelligent mobility aids. It uses motion sensors to sense changes in hip joints and knees, and uses artificial intelligence to analyze and switch the motor to make precise power to assist the user. In the future, B-Temia Asia will market high-quality human-centered medical services to all parts of Asia to help people with mobility restrictions in their lives to regain their autonomy, and let modern technology solutions bring life changes to those who want to regain their mobility.